Glucokinase Regulatory Network in Pancreatic β-Cells and Liver

Author:

Baltrusch Simone1,Tiedge Markus2

Affiliation:

1. Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany

2. Institute of Medical Biochemistry and Molecular Biology, University of Rostock, Rostock, Germany

Abstract

The low-affinity glucose-phosphorylating enzyme glucokinase (GK) is the flux-limiting glucose sensor in liver and β-cells of the pancreas. Furthermore, GK is also expressed in various neuroendocrine cell types. This review describes the complex network of GK regulation, which shows fundamental differences in liver and pancreatic β-cells. Tissue-specific GK promoters determine a higher gene expression level and glucose phosphorylation capacity in liver than in pancreatic β-cells. The second hallmark of tissue-specific GK regulation is based on posttranslational mechanisms in which the high-affinity regulatory protein in the liver undergoes glucose- and fructose-dependent shuttling between cytoplasm and nucleus. In β-cells, GK resides outside the nucleus but has been reported to interact with insulin secretory granules. The unbound diffusible GK fraction likely determines the glucose sensor activity of insulin-producing cells. The bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) has been identified as an activating binding partner of β-cell GK, increasing the Vmax value of the enzyme, while the S0.5 value for glucose remains unchanged. This effect is likely due to stabilization of a catalytically active enzyme conformation. The identification of chemical activators of GK paved the way to determining its crystal structure, revealing a catalytically less active super open conformation and a catalytically active closed conformation with a normal affinity for glucose. The glucose sensor function of GK in liver and β-cells results from the synergy of its regulatory properties with its transcriptionally and posttranslationally controlled levels. These factors have to be taken into account in designing pharmacotherapy for type 2 diabetes.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3